Literature DB >> 9794740

Transcription factor decoy for nuclear factor-kappaB inhibits tumor necrosis factor-alpha-induced expression of interleukin-6 and intracellular adhesion molecule-1 in endothelial cells.

N Tomita1, R Morishita, S Tomita, K Yamamoto, M Aoki, H Matsushita, S Hayashi, J Higaki, T Ogihara.   

Abstract

BACKGROUND: Several cytokines and adhesion molecules released from endothelium play an important role in inflammation, immune responses, and probably atherogenesis.
OBJECTIVE: To determine whether the transcription factor nuclear factor-kappaB mediated expression of these genes involved in the inflammatory response of endothelial cells to tumor necrosis factor-alpha, by using transcription factor decoy oligodeoxynucleotides. DESIGN AND METHODS: We first transfected fluorescein isothiocyanate (FITC)-labeled double-stranded oligodeoxynucleotides into endothelial cells by a cationic liposome-mediated method of gene transfer. We then confirmed that the decoy oligodeoxynucleotides could block binding of nuclear factor-kappaB to its specific cis element effectively. In addition, we transfected the reporter gene chloramphenicol acetyltransferase driven by three repeated nuclear factor-kappaB binding sequences in the promoter and enhancer region.
RESULTS: FITC-labeled oligodeoxynucleotides were detected in the nuclei of approximately 70% of the total cells. Tumor necrosis factor--stimulated expression of chloramphenicol acetyltransferase was partially inhibited by transfection of nuclear factor-kappaB decoy oligodeoxynucleotides, but not by transfection of scrambled oligodeoxynucleotides. Also nuclear factor-kappaB decoy oligodeoxynucleotides but not scrambled oligodeoxynucleotides inhibited tumor necrosis factor-induced expression of interleukin-6 and intracellular adhesion molecule-1 both at the messenger RNA and at protein level (assessed by reverse transcription-polymerase chain reaction and enzyme-linked immunosorbent assay).
CONCLUSION: Our results demonstrate that nuclear factor-kappaB decoy oligodeoxynucleotides transfected by cationic liposome method inhibited tumor necrosis factor--induced expression of interleukin-6 and intracellular adhesion molecule-1 in endothelial cells.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9794740     DOI: 10.1097/00004872-199816070-00013

Source DB:  PubMed          Journal:  J Hypertens        ISSN: 0263-6352            Impact factor:   4.844


  11 in total

Review 1.  Therapeutic applications of transcription factor decoy oligonucleotides.

Authors:  M J Mann; V J Dzau
Journal:  J Clin Invest       Date:  2000-11       Impact factor: 14.808

Review 2.  NF-kappaB in the survival and plasticity of neurons.

Authors:  Mark P Mattson
Journal:  Neurochem Res       Date:  2005 Jun-Jul       Impact factor: 3.996

3.  Inhibition of cerebral vascular inflammation by brain endothelium-targeted oligodeoxynucleotide complex.

Authors:  Jing Hu; Daniah Al-Waili; Aishlin Hassan; Guo-Chang Fan; Mei Xin; Jiukuan Hao
Journal:  Neuroscience       Date:  2016-04-27       Impact factor: 3.590

4.  Endotoxin-Induced IL-6 Promoter Activation in Skeletal Muscle Requires an NF-κB Site.

Authors:  David Yeagley; Charles H Lang
Journal:  Int J Interferon Cytokine Mediat Res       Date:  2010-01-01

5.  Encapsulation of NF-kappaB decoy oligonucleotides within echogenic liposomes and ultrasound-triggered release.

Authors:  Kyle D Buchanan; Shao-Ling Huang; Hyunggun Kim; David D McPherson; Robert C MacDonald
Journal:  J Control Release       Date:  2009-10-03       Impact factor: 9.776

Review 6.  Decoy Technology as a Promising Therapeutic Tool for Atherosclerosis.

Authors:  Maryam Mahjoubin-Tehran; Yong Teng; Amin Jalili; Seyed Hamid Aghaee-Bakhtiari; Alexander M Markin; Amirhossein Sahebkar
Journal:  Int J Mol Sci       Date:  2021-04-23       Impact factor: 5.923

7.  Inhibitory effect of ribbon-type NF-kappaB decoy oligodeoxynucleotides on osteoclast induction and activity in vitro and in vivo.

Authors:  Yasuo Kunugiza; Tetsuya Tomita; Naruya Tomita; Ryuichi Morishita; Hideki Yoshikawa
Journal:  Arthritis Res Ther       Date:  2006       Impact factor: 5.156

8.  4R-Cembranoid Improves Outcomes after 6-Hydroxydopamine Challenge in Both In vitro and In vivo Models of Parkinson's Disease.

Authors:  Jing Hu; P A Ferchmin; Ann M Hemmerle; Kim B Seroogy; Vesna A Eterovic; Jiukuan Hao
Journal:  Front Neurosci       Date:  2017-05-29       Impact factor: 4.677

9.  Regulation of platelet-activating factor-mediated interleukin-6 promoter activation by the 48 kDa but not the 45 kDa isoform of protein tyrosine phosphatase non-receptor type 2.

Authors:  Geneviève Hamel-Côté; Fanny Lapointe; Steeve Véronneau; Marian Mayhue; Marek Rola-Pleszczynski; Jana Stankova
Journal:  Cell Biosci       Date:  2019-06-25       Impact factor: 7.133

10.  UVB irradiation regulates ERK1/2- and p53-dependent thrombomodulin expression in human keratinocytes.

Authors:  Huey-Chun Huang; Tsong-Min Chang; Yu-Jia Chang; Hsin-Yun Wen
Journal:  PLoS One       Date:  2013-07-02       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.